|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, October 18, 2021 )
Market Overview
A pregnancy test determines whether a woman is pregnant or not. The two basic approaches are testing for human pregnancy hormones in blood or urine and ultrasonography. At the same time, fertility testing is the process of assessing fertility in general and determining the "fertile window" in the menstrual cycle.
View full report: https://www.datamintelligence.com/research-report/pregnancy-and-fertility-testing-products-market
Market Dynamics
The factors driving the market growth are the latest technological developments in pregnancy & fertility testing
An increase in technological advancements in pregnancy & fertility testing is expected to drive the market in the forecast period
Women's health innovations are fast reshaping the health care landscape. The FDA has approved the first-ever digital contraception, Natural Cycle's fertility tracking software, which pairs with a basal thermometer to allow women to prepare for or avoid pregnancy through temperature logging.
Antibodies are used in pregnancy tests to detect human chorionic gonadotropin (hCG). It is an excellent pregnancy indicator since it rises swiftly and reliably in early pregnancy and may be found in urine. The most advanced home pregnancy test available today assesses the level of hCG detected in urine and claims to offer women trustworthy findings within a few weeks of pregnancy.
In Germany, over 15 different home pregnancy tests are now available for purchase over the counter. Modern pregnancy tests employ a form of technology known as a lateral flow device (LFD). A lateral flow device comprises many distinct types of paper that have pores (small holes) of varying sizes.
On August 20, 2020, ACON Laboratories, Inc. obtained FDA Over The Counter (OTC) clearance for its Distinct® Early Detection Pregnancy test. The test detects human chorionic gonadotropin (hCG) in urine qualitatively and can help users predict pregnancy as early as six days before the missed period.
On July 2, 2018, Merck launched QBOX IVF and the new Geri® Assess 2.0 as part of its new technologies for improved efficiency in fertility labs.
Segmentation
By Devices
• Digital Device
• Line-Indicator Devices
By Distribution Channel
• Pharmacies
• Gynecology & Fertility Clinics
• Online Sales
• Others
Download free sample: https://www.datamintelligence.com/download-sample/pregnancy-and-fertility-testing-products-market
Geographical Analysis
North America region accounted for the largest market share in the global pregnancy & fertility testing products market
With the increasing prevalence of infertility incidence and product launches, this region is expected to dominate the market
It is estimated that over 12% of women in the United States have difficulty getting pregnant. Infertility is predicted to become increasingly common as people wait longer to start having children. After a year of trying, approximately 6% of married women aged 15 to 44 in the United States cannot conceive (infertility).
In addition, approximately 12% of women aged 15 to 44 in the United States have trouble getting pregnant or bringing a pregnancy to term (impaired fecundity).
According to statistics, 92 million women in the U.S. used home pregnancy tests in 2020.
On December 13th, 2017, a start-up in the United States, Lia launched a flushable pregnancy test made of sustainable, biodegradable materials, which they claim is the first of its type.
Competitive Landscape
The global pregnancy & fertility testing products market is highly competitive with the increasing demand for home-testing kits and technological advancements in recent product launches.
Some of the major key players in the global pregnancy & fertility testing products market are Quidel Corporation, Alere Inc, Church & Dwight Co., Inc., bioMrieux SA, Geratherm Medical AG, Abbott Laboratories, Procter & Gamble Co., Biosynex, and Swiss Precision Diagnostics GmbH
Topic's you may be interested, Hematocrit Test Devices Market, Orthopedic Regenerative Surgical Products Market, Coagulation Monitoring Products Market, Cardiometabolic Monitoring Products Market, Infectious Disease Testing Products Market
DataM Intelligence
Sai Kiran
+1 877 441 4866
pr@datamintelligence.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
